Gastric Cancer Cells Induce Human CD4+Foxp3+ Regulatory T Cells Through the Production of TGF-β1
Overview
Authors
Affiliations
Aim: To elucidate the molecular and cellular features responsible for the increase of regulatory T cells (Tregs) in gastric cancer.
Methods: The frequencies of CD4(+)Foxp3(+) Tregs and the level of transforming growth factor-β1 (TGF-β1) were analyzed from 56 patients with gastric cancer by flow cytometry and enzyme-linked immunosorbent assay respectively. Foxp3 gene expression was analyzed by real-time polymerase chain reaction. The gastric cancer microenvironment was modeled by establishing the co-culture of gastric cancer cell line, MGC-803, with sorting CD4(+) T cells. The normal gastric mucosa cell line, GES-1, was used as the control. The production of TGF-β1 was detected in supernatant of MGC and GES-1. The carboxyfluorescein diacetatesuccinimidyl ester (CFSE) dilution assay was performed to evaluate the proliferation characteristics of induced Tregs. Neutralizing anti-TGF-β1 antibody was added to the co-culture system for neutralization experiments.
Results: The level of serum TGF-β1 in gastric cancer patients (15.1 ± 5.5 ng/mL) was significantly higher than that of the gender- and age-matched healthy controls (10.3 ± 3.4 ng/mL) (P < 0.05). Furthermore, the higher TGF-β1 level correlated with the increased population of CD4(+)Foxp3(+) Tregs in advanced gastric cancer (r = 0.576, P < 0.05). A significant higher frequency of CD4(+)Foxp3(+) Tregs was observed in PBMCs cultured with the supernatant of MGC than GES-1 (10.6% ± 0.6% vs 8.7% ± 0.7%, P < 0.05). Moreover, using the purified CD4(+)CD25(-) T cells, we confirmed that the increased Tregs were mainly induced from the conversation of CD4(+)CD25(-) naive T cells, and induced Tregs were functional and able to suppress the proliferation of effector T cells. Finally, we demonstrated that gastric cancer cells induced the increased CD4(+)Foxp3(+) Tregs via producing TGF-β1. Gastric cancer cells upregulated the production of TGF-β1 and blockade of TGF-β1 partly abrogated Tregs phenotype.
Conclusion: Gastric cancer cell can induce Tregs development via producing TGF-β1, by which the existence of cross-talk between the tumor and immune cells might regulate anti-tumor immune responses.
Molecular Mechanism for Malignant Progression of Gastric Cancer Within the Tumor Microenvironment.
Matsuoka T, Yashiro M Int J Mol Sci. 2024; 25(21).
PMID: 39519285 PMC: 11546171. DOI: 10.3390/ijms252111735.
T lymphocyte‑related immune response and immunotherapy in gastric cancer (Review).
Zhang Z, Zhang W, Liu X, Yan Y, Fu W Oncol Lett. 2024; 28(5):537.
PMID: 39319215 PMC: 11421013. DOI: 10.3892/ol.2024.14670.
Nagashima A, Okimoto K, Nakagawa R, Akizue N, Matsumura T, Oura H Sci Rep. 2023; 13(1):19661.
PMID: 37952025 PMC: 10640628. DOI: 10.1038/s41598-023-47000-3.
Maruyama T, Miyazaki H, Lim Y, Gu J, Ishikawa M, Yoshida T Front Immunol. 2023; 14:1049713.
PMID: 36814928 PMC: 9939626. DOI: 10.3389/fimmu.2023.1049713.
Arenas-Luna V, Montesinos J, Cortes-Morales V, Navarro-Betancourt J, Peralta-Ildefonso J, Cisneros B Curr Issues Mol Biol. 2023; 45(1):268-285.
PMID: 36661506 PMC: 9857683. DOI: 10.3390/cimb45010020.